IR
Disc Medicine, Inc.
IRON · NASDAQ
$70.06 -6.16% (-$4.60)
1M -11.14%
Market Cap $2.85B
P/E Ratio -
Div. Yield -
ROE 37.17%
Bulios Fair Price
$35.64
49.1% downside
Current Price
$70.06
Undervalued Fair Value Overvalued
According to Bulios Fair Price, IRON is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
45 /100
Fair P/B 4.42x
PEG N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 61.21%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 33.45%
ROIC 38.24%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage -68.14x
Debt/Equity 0.09x
Current ratio 24.14x
Stability
4 /100
Unstable Profitable years 0
Beta 2.05x
EPS volatility 75.04%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IRON
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John D. Quisel
Employees
165
Headquarters
Watertown
Upcoming events
05 NOV
Earnings
Upcoming earnings report